Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Eupraxia Pharmaceuticals Inc. (EPRX) had Free Cash Flow per Share of $-0.52 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-7.01M |
|
-- |
|
-- |
|
$6.88M |
|
$-6.88M |
|
$0.51M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.37M |
|
$-6.88M |
|
$-6.82M |
|
36.91M |
|
36.91M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$91.40M |
|
$0.68M |
|
$0.95M |
|
$92.35M |
|
$3.81M |
|
$0.09M |
|
$0.09M |
|
$3.91M |
|
$56.74M |
|
$88.44M |
|
$88.44M |
|
50.60M |
|
| Cash Flow Statement Financials | |
$-18.82M |
|
$-0.40M |
|
$74.57M |
|
$33.10M |
|
$88.96M |
|
$55.86M |
|
$3.06M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.98 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.22M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-11.23% |
|
-7.20% |
|
-6.90% |
|
-7.19% |
|
$1.75 |
|
|
Free Cash Flow per Share |
$-0.52 |
$-0.51 |
|